Hair loss trial pulled before it even started
NCT ID NCT02849470
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This trial aimed to test a combination of platelet-rich plasma and stem cells from fat tissue for treating male and female pattern hair loss. It was designed to compare different mixtures injected into the scalp. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Platelet-rich plasma and fat-derived stem cells
- What this could lead to
- If it had worked, this could point toward a regenerative treatment for hair loss using a person's own cells.
- What could go wrong
- The trial was withdrawn before enrolling anyone, so no data exists. Early-phase studies often fail to show benefit or have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kenneth Williams, DO
Irvine, California, 92618, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tiny needles boost hair growth in balding men?
- A battle for your hair: herbal oil vs. minoxidil serum in a Head-to-Head trial
- Can light boost PRP's power against hair loss?
- Hair loss linked to gut and scalp bacteria in new study
- Baldness breakthrough? own cells injected into scalp to regrow hair
- New laser could spark hair regrowth in balding patients